VP, Global Program Lead - Cell Therapy

Position Summary:

The Global Program Lead (GPL) will serve as the “point of accountability” for two novel cell therapies in multiple myeloma. These programs include ongoing pivotal studies with potential to redefine the treatment paradigm.  The GPL role is accountable for leading the Global Program Teams and orchestrating the design and execution of a global integrated program strategy from candidate nomination through drug development to successful launch and commercialization. The GPL develops, leads, and inspires a high performing matrix. They are responsible for cross-functional stakeholder relationships and input to ensure end to end understanding of upstream and downstream alignment and business implications for the strategy, and its evolution as emerging data and competitive insights unfold. In addition to leading these programs, the GPL will play a key role in advancing the BMS multiple myeloma disease area strategy.

Technical/Functional Responsibilities:

Develops and manages product strategy and drug development programs to ensure approval and commercial success

• Defines and executes the strategic integrated development plan (IDP) in partnership with the cross functional GPT members

• Participates in regulatory filings (NDA, BLA filings), engaging with Health Authorities and/or Advisory Committees

• Leads team to develop program strategy and clinical program, commercialization strategy plans, business case development, and understands how access, pricing and reimbursement needs for supporting value proposition will inform trial design

• Builds and maintains collaborative relationships with external stakeholders and appropriately incorporates insights and advice to maximize program impact

• Actively supports Investor Relations and Public Affairs in managing external BMS communications

Integrates commercialization inputs and deliverables to design the program strategy that enables approval of meaningfully differentiated assets with potential to maximize asset value

• Understands necessary commercial inputs needed to inform the end-to-end development process leading to regulatory approval and successful commercialization 

• Integrates market inputs into the integrated development plan, including clinical plans and labeling strategy; Appreciates translation of clinical data into claims and considerations for label development

• Understands and contributes to development of forecasts and investment scenarios, how to assess risk and conduct valuations, and implications for decision making

• Contributes to the development of brand hallmarks and brand strategy, understanding the relationship to clinical trial design

• In partnership with Medical Affairs, supports development of KOL plans and engagements, and leverages KOL input in context of development programs and communicating evidence

• Supports commercial needs and recommendations to guide CMC and GPS on trade packaging and commercial product

Clinical Trial Design, Execution, and Interpretation

• Utilizes various resources to design clinical trials that are competitively differentiating

• Actively participates with Health Authorities in finalizing clinical design and adequate endpoints

• Understands clinical trial operational complexities from study start up through enrollment, quality assurance, and study readout

• Has an active role in analysis and/or interpretation of clinical data and translation into scientific communication strategy, including publications, and commercial strategy

• <